117 related articles for article (PubMed ID: 9669286)
1. Fibroblast growth factor-2 free from extracellular matrix is increased in papillary thyroid carcinomas and Graves' thyroids.
Emoto N; Onose H; Sugihara H; Minami S; Shimizu K; Wakabayashi I
Thyroid; 1998 Jun; 8(6):491-7. PubMed ID: 9669286
[TBL] [Abstract][Full Text] [Related]
2. A subpopulation of fibroblast growth factor-2-binding heparan sulfate is lost in human papillary thyroid carcinomas.
Emoto N; Shimizu K; Onose H; Ishii S; Sugihara H; Wakabayashi I
Thyroid; 2000 Oct; 10(10):843-9. PubMed ID: 11081250
[TBL] [Abstract][Full Text] [Related]
3. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue.
Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H
J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450
[TBL] [Abstract][Full Text] [Related]
4. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues.
Marti U; Ruchti C; Kämpf J; Thomas GA; Williams ED; Peter HJ; Gerber H; Bürgi U
Thyroid; 2001 Feb; 11(2):137-45. PubMed ID: 11288982
[TBL] [Abstract][Full Text] [Related]
6. Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma.
Pohl M; Grabellus F; Worm K; Arnold G; Walz M; Schmid KW; Sheu-Grabellus SY
J Clin Pathol; 2017 Jan; 70(1):33-39. PubMed ID: 27371612
[TBL] [Abstract][Full Text] [Related]
7. Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves' disease.
Hsiao PJ; Tsai JH
J Formos Med Assoc; 1994; 93(11-12):925-32. PubMed ID: 7633196
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease.
Sancak S; Hardt A; Singer J; Klöppel G; Eren FT; Güllüoglu BM; Sen LS; Sever Z; Akalin NS; Eszlinger M; Paschke R
Thyroid; 2010 May; 20(5):505-11. PubMed ID: 20450431
[TBL] [Abstract][Full Text] [Related]
9. Tissue calmodulin levels in normal and Graves' thyroids.
Inaba M; Hamada N; Morii H; Nishizawa Y; Yamakawa J; Ohno M; Tsuda S; No J; Kanayama Y; Saitoh H
Endocrinol Jpn; 1984 Dec; 31(6):711-7. PubMed ID: 6398218
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein.
Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S
J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985
[TBL] [Abstract][Full Text] [Related]
11. Presence of TSH receptor in thyroid neoplasms.
Ichikawa Y; Saito E; Abe Y; Homma M; Muraki T
J Clin Endocrinol Metab; 1976 Feb; 42(2):395-8. PubMed ID: 177443
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease.
Erkiliç S; Koçer NE
Endocr Pathol; 2005; 16(1):63-6. PubMed ID: 16000848
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and estrogen receptors in thyroid carcinomas.
Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Noguchi M; Matsubara F
J Surg Oncol; 1991 Jul; 47(3):165-9. PubMed ID: 2072699
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of basic fibroblast growth factor in porcine thyroids.
Emoto N; Isozaki O; Arai M; Murakami H; Shizume K; Baird A; Tsushima T; Demura H
Endocrinology; 1991 Jan; 128(1):58-64. PubMed ID: 1702706
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
17. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.
Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM
Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591
[TBL] [Abstract][Full Text] [Related]
18. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands.
Kanamori A; Abe Y; Yajima Y; Manabe Y; Ito K
J Clin Endocrinol Metab; 1989 May; 68(5):899-903. PubMed ID: 2715291
[TBL] [Abstract][Full Text] [Related]
20. Expression, localization, and thyrotropin regulation of cathepsin D in human thyroid tissues.
Métayé T; Kraimps JL; Goujon JM; Fernandez B; Quellard N; Ingrand P; Barbier J; Bégon F
J Clin Endocrinol Metab; 1997 Oct; 82(10):3383-8. PubMed ID: 9329373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
